Document:

ex_360013.htm

Exhibit 10.4

One-Time Transaction Bonus Agreement by and between the Company, Wainwright Holdings, Inc., and John Love

 

 

ONE TIME TRANSACTION BONUS AGREEMENT

 

This ONE TIME TRANSACTION BONUS AGREEMENT, dated as of April 18, 2022 (the “Agreement”), is entered into by and among Concierge Technologies, Inc. (“Concierge”) and its wholly-owned subsidiary, Wainwright Holdings, Inc., (“Wainwright” or the “Company”), and John Love (the “Employee”).

 

WHEREAS, the Employee is currently employed by the Wainwright’s wholly owned subsidiary United States Commodity Funds LLC (“USCF”) and provides services to USCF, USCF Advisers LLC, a Delaware limited liability company (“USCF Advisers”), and certain of the funds operated or advised by USCF and USCF Advisers; and

 

WHEREAS, the Company desires to enter into this Agreement with the Employee in order to reward the Employee in connection with an Eligible Event (as defined below).

 

NOW, THEREFORE, in consideration of the respective agreements of the parties contained herein, it is agreed as follows:

 

	 	
			1.

				
			TERM OF AGREEMENT. Subject to the terms and conditions set forth below, this Agreement shall commence as of the date set forth above (the “Effective Date”) and terminate at the end of three (3) years from the Effective Date (the “Term”) unless the sooner to occur of (a) the satisfaction of payment of amounts or that may be owed to Employee pursuant to this Agreement due to the closing of an Eligible Event, subject to the provisions set forth in this Agreement; and (b) except as provided in Section 3(d), the Employee’s Termination of Employment for any reason prior to an Eligible Event; and (c) the Company and the Employee mutually agree to terminate this Agreement prior to the end of the Term.

			

 

 

	 	
			2.

				
			DEFINITIONS. For purposes of this Agreement:

			

 

 

	 	
			(a)

				
			“Affiliates” shall refer to any parent, subsidiary, or other entity (including but not limited to or any parent or subsidiary of any such parent, subsidiary or other entity) connected to the Company, USCF, and/or USCF Advisers by common ownership and control, regardless of corporate form.

			

 

 

	 	
			(b)

				
			“Cause” shall mean any gross or willful misconduct by the Employee, including but not limited to, the following: (i) an act of fraud against Concierge, Wainwright, USCF, USCF Advisers, and/or their Affiliates; (ii) failure or any refusal to implement or undertake the directives of USCF’s and/or USCF Advisers’ and Concierge’s Board of Directors and/or their Affiliates; (iii) breach of fiduciary duty to the Concierge, Wainwright, USCF, USCF Advisers, and/or their Affiliates or engaging in conduct that causes material injury, monetary, reputational or otherwise, to Concierge, Wainwright, USCF, USCF Advisers, and/or their Affiliates; (iv) engaging in conduct that reflects adversely on Concierge, Wainwright, USCF, USCF Advisers, and/or their Affiliates, and/or that affects the Employee’s ability to perform the Employee’s duties, and/or or that brings the Employee into public disrepute or scandal; (v) arrest for, indictment for, or being formally charged with, the commission of a felony or commission of a crime, whether or not a felony; (vi) violation of federal, state or local tax laws; (vii) dependence on alcohol or drugs without the supervision of a physician or the illegal use, possession or sale of drugs; (viii) theft, misappropriation, embezzlement or conversion of the assets or opportunities of Concierge, Wainwright, USCF, USCF Advisers, and/or their Affiliates; (ix) failure by the Employee to promptly and/or adequately perform the duties assigned to the Employee by Concierge, Wainwright, USCF, USCF Advisors and/or its Affiliates, as determined by the USCF’s and Concierge’s Board of Directors in their discretion; (x) failure by the Employee to promptly and/or adequately perform the duties assigned to the Employee by USCF Advisers and/or its Affiliates, as determined by USCF Advisers’ and Concierge’s Board of Directors in their discretion; (xi) a material breach of the terms, covenants or representations of that certain offer letter agreement entered into between USCF and the Employee, dated May 20, 2015, and/or any agreement entered into between the Employee and Wainwright, USCF, USCF Advisers, or their Affiliates; or (xiii) a violation of policies of Concierge, Wainwright, USCF, USCF Advisers, and/or their Affiliates.

			

 

 

	 	
			(c)

				
			“Change of Control” means (i) the acquisition of equity interests of the Company, USCF, or USCF Advisers by any one Person, or more than one Person acting as a group, whether through merger, consolidation, restructuring or otherwise, if upon such acquisition, such Person or group acquires ownership interests or equity interests of the Wainwright that, together with equity interests already held by such Person or group, constitutes more than 50% of (x) the total voting power of the ownership interests or equity interests of the Company, USCF, or USCF Advisers, and/or (z) the fair market value of the Company; or (ii) the sale of all or substantially all of the assets of the Company, USCF, or USCF Advisers. Notwithstanding anything to the contrary in this Agreement, Change of Control shall not include (i) reorganization, restructuring, recapitalization, reclassification, merger, or transfer of assets within the Company, USCF, or USCF Advisers; (ii) change in ownership of ownership interests or equity interests of the Company, USCF, or USCF Advisers between only the existing holders of ownership interests or equity interests of the Company, USCF, or USCF Advisers; and/or (iii) a sale of less than substantially all of the assets of the Company, USCF, or USCF Advisers (i.e. a sale of a division, operating segment or any portion of business). For purposes of this Agreement, the term Change of Control does not include the parent of the Company and only includes the Company and its two (2) wholly owned subsidiaries, USCF and USCF Advisers. For purposes of this Agreement, the term Change of Control is intended to be interpreted in a manner consistent with the meaning of a change in control under Section 409A of the Code.

			

 

 

	 	
			(d)

				
			“Disability” shall mean that the Employee is unable to engage in any substantial gainful activity due to a medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than four (4) months.

			

 

 

	 	
			(e)

				
			“Eligible Event” means the closing of a transaction that results in a Change of Control of Wainwright, USCF, USCF Advisers or if USCF or USCF Advisers sells one or more of their funds under their respective management whether or not a sale of a fund or funds causes a 50% or more aggregate change in assets under management for USCF or USCF Advisers.

			

 

 

	 	
			(f)

				
			“Net Proceeds” means the gross proceeds generated from an Eligible Event, less a reduction for all outstanding debts, liabilities, obligations of Wainwright, USCF and/or USCF Advisers to its employees, managers, members agents and advisors (which may include USCF employees discretionary bonus pool amount) and any costs or expenses incurred or allocated in connection with such Eligible Event.

			

 

 

 

	 	
			(g)

				
			“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

			

 

 

	 	
			(h)

				
			“Termination of Employment” means the Employee’s separation from service with USCF, or USCF Advisers, and/or their Affiliates, pursuant to that certain Offer of Promotion and Employment in New Role between the Employee and USCF, dated May 12, 2015 (the “2015 Agreement”) for any reason, including, but not limited to, within the meaning of Section 409A of the Code. Notwithstanding the foregoing, the Employee will not be considered to have a separation from service while the Employee is on military leave, sick leave, vacation or other bona fide leave of absence.

			

 

 

	 	
			(i)

				
			“Termination Without Cause” means Termination of Employment by the Company, USCF, or USCF Advisers for any reason other than death, Disability, or Cause.

			

 

 

	 	
			3.

				
			BONUS PAYMENTS

			

 

 

	 	
			(a)

				
			CHANGE OF CONTROL BONUS.

			

 

 

	 	
			i.

				
			Subject to the terms and conditions of this Agreement, the Employee shall be entitled to a bonus payment equal to five percent (5%) of the Net Proceeds received by the Company, USCF, or USCF Advisers, upon an Eligible Event, provided, however, the value of such payment, whether in cash or stock, to Employee shall not exceed five million dollars ($5,000,000) (such bonus, “Change of Control Bonus”). The Change of Control Bonus paid to Employee shall be paid in the same form as payable to the equity holders of the Company, USCF or USCF Advisers and may consist of cash, securities or a combination thereof.

			

 

 

	 	
			ii.

				
			In the event that any portion of the Net Proceeds payable in connection with the consummation of any transaction constituting a Change of Control is subject to any escrow, holdback, earnout or similar delay or deferral of payment, the amount otherwise payable hereunder shall be subject to the same escrow, holdback, earnout, delay or deferral in the same proportion and subject to the same terms and conditions of payment as otherwise applicable to the holders of the equity securities of the Company, USCF or USCF Advisers to the extent permitted under Section 409A of the Code. Any such delayed or deferred amount shall be payable at the same time and in the same proportion as otherwise payable to the equity holders of the Company, USCF or USCF Advisers to the extent permitted under Section 409A of the Code.

			

 

 

	 	
			iii.

				
			Notwithstanding the foregoing, if the Change of Control results in proceeds that include both a determinable amount based on current assets or revenue in place at the time of the Change of Control, and a contingent amount to be determined by future performance, product additions, revenue growth, or asset growth, the calculation of the Change of Control Bonus shall be based on the determinable amount and shall exclude any contingent amounts.

			

 

 

	 	
			iv.

				
			Payment of the Change of Control Bonus, or any portion thereof, shall be made within a reasonable period of time following the Eligible Event or the last of a series of transactions constituting an Eligible Event (or any applicable deferred payment date) and, in no event, later than sixty (60) days following such Eligible Event (or any applicable deferred payment date).

			

 

 

	 	
			(b)

				
			Any payment under this Agreement shall be subject to the execution and delivery of a release in favor of Concierge, Wainwright, USCF, USCF Advisers, in a form acceptable to the Company in its sole discretion.

			

 

 

	 	
			(c)

				
			No Change of Control Bonus will be payable to the Employee if the Employee incurs a Termination of Employment at any time prior to an Eligible Event, provided, however, that in the event of the Employee’s Termination of Employment due to Termination Without Cause, as provided herein and notwithstanding the 2015 Agreement, during the six (6) month period prior to the occurrence of an Eligible Event, the Employee shall be eligible to receive payment in connection with that specific Eligible Event in accordance with the terms of this Agreement, provided, further, that the Employee shall not be eligible for payments in connection with any future Eligible Events.

			

 

 

	 	
			(d)

				
			Notwithstanding anything to the contrary in this Agreement, in the event that the Employee is eligible to receive payments under this Agreement, whether such payment is a Change of Control Bonus or a payment made in securities, on more than one occasion during the term of the Employee’s employment and/or engagement with the Company, USCF, or USCF Advisers, and/or their Affiliates the total value of the payments received by the Employee, whether in cash or securities, pursuant to this Agreement shall not exceed five million dollars ($5,000,000).

			

 

 

	 	
			4.

				
			280G PROTECTION.

			

 

 

	 	
			(a)

				
			Notwithstanding Section 3, in the event that the Employee shall become entitled to payment and/or benefits provided by this Agreement or any other amounts in the “nature of compensation” (whether pursuant to the terms of this Agreement or any other plan, arrangement or agreement with the Company, USCF, or USCF Advisers, by any Person whose actions result in a change of ownership or effective control covered by Section 280G(b)(2) of the Internal Revenue Code (the “Code”) or any Person affiliated with the Company, USCF, or USCF Advisers or such Person) as a result of such change in ownership or effective control (collectively the “Company Payments”), and such Company Payments will be subject to the tax (the “Excise Tax”) imposed by Section 4999 of the Code (and any similar tax that may hereafter be imposed by any taxing authority), the Company shall pay to the Employee the greater of the following, whichever yields to the Employee the highest net after-tax amount (after taking into account federal, state, local and social security (including Medicare) taxes at the maximum marginal rates) (x) the Company Payments or (y) one dollar less than the amount of the Company Payments that would subject the Employee to the Excise Tax. In the event that the Company Payments are required to be reduced pursuant to the foregoing sentence, then the Company Payments shall be reduced as mutually agreed between the Company and the Employee or, in the event the parties cannot agree, in the following order (1) any lump sum severance based on Base Salary or Annual Bonus, (2) any other cash amounts payable to the Employee, (3) any noncash benefits valued as parachute payments; and (4) acceleration of vesting of any equity.

			

 

 

 

	 	
			(b)

				
			For purposes of determining whether any of the Company Payments will be subject to the Excise Tax and the amount of such Excise Tax, (x) the Company Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base amount” (as defined under Code Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the opinion of the Company’s independent certified public accountants appointed prior to any change in ownership (as defined under Section 280G(b)(2) of the Code) or tax counsel selected by such accountants or the Company (the “Accountants”) such Company Payments (in whole or in part) either expressly do not constitute “parachute payments,” or represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the “base amount” or are otherwise not subject to the Excise Tax, and (y) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants. All determinations hereunder shall be made by the Accountants which shall provide detailed supporting calculations both to the Company and the Employee at such time as it is requested by the Company or the Employee. If the Accountants determine that payments under this Agreement must be reduced pursuant to this paragraph, they shall furnish the Employee with a written opinion to such effect. The determination of the Accountants shall be final and binding upon the Company and the Employee.

			

 

 

	 	
			(c)

				
			In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the Employee shall permit the Company to control issues related to the Excise Tax (at its expense), provided that such issues do not potentially materially adversely affect the Employee, but the Employee shall control any other issues. In the event the issues are interrelated, the Employee and the Company shall in good faith cooperate so as not to jeopardize resolution of either issue, but if the parties cannot agree the Employee shall make the final determination with regard to the issues. In the event of any conference with any taxing authority regarding the Excise Tax or associated income taxes, the Employee shall permit the representative of the Company to accompany the Employee, and the Employee and the Employee’s representative shall cooperate with the Company and its representative.

			

 

 

	 	
			5.

				
			NOTICES. For the purposes of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when Personally delivered or sent by certified mail, return receipt requested, postage prepaid, addressed to the respective addresses last given by each party to the other.

			

 

 

	 	
			6.

				
			GOVERNING LAW. This Agreement will be governed and construed and enforced in accordance with the laws of the State of California without regard to its conflicts of law rules. The parties hereby submit to the jurisdiction and venue of any local, state or federal court located within Contra Costa County, California, for resolution of any and all claims, causes of action or disputes arising out of, related to or concerning this Agreement and the parties agree to waive any claim relating to forum non conveniens. Both parties further acknowledge and agree that any suit, action or proceeding, whether claim or counterclaim, of any kind or nature brought by either party arising out of the interpretation, enforcement or breach of this Agreement shall be resolved by a judge alone, and both parties hereby waive and forever renounce the right to a trial before a civil jury of any such suit, action or proceeding.

			

 

 

	 	
			7.

				
			WITHHOLDING. The payment of any amount pursuant to this Agreement shall be subject to applicable withholding and payroll taxes, and such other deductions as may be required or permitted by applicable law.

			

 

 

	 	
			8.

				
			SECTION 409A OF THE CODE. It is intended that the provisions of this Agreement comply with Section 409A of Code and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”), and all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Code Section 409A. If any provision of this Agreement (or of any award of compensation, including equity compensation or benefits) would cause the Employee to incur any additional tax or interest under Code Section 409A, the Company shall, upon the specific request of the Employee, use its reasonable business efforts to in good faith reform such provision to comply with Code Section 409A; provided, that to the maximum extent practicable, the original intent and economic benefit to the Employee and the Company of the applicable provision shall be maintained, but the Company shall have no obligation to make any changes that could create any additional economic cost or loss of benefit to the Company. The Company shall timely use its reasonable business efforts to amend any plan or program in which the Employee participates to bring it in compliance with Code Section 409A. Notwithstanding the foregoing, the Company shall have no liability with regard to any failure to comply with Code Section 409A so long as it has acted in good faith with regard to compliance therewith.

			

 

 

	 	
			9.

				
			SURVIVORSHIP. Except as otherwise expressly set forth in this Agreement, upon the expiration of the Term, the respective rights and obligations of the parties shall survive such expiration to the extent necessary to carry out the intentions of the parties as embodied in this Agreement. This Agreement shall continue in effect until there are no further rights or obligations of the parties outstanding hereunder and shall not be terminated by either party without the express prior written consent of both parties.

			

 

 

	 	
			10.

				
			COUNTERPARTS. This Agreement may be executed in counterparts (including by fax or pdf) which, when taken together, shall constitute one and the same agreement of the parties.

			

 

 

	 	
			11.

				
			MISCELLANEOUS. No provision of this Agreement may be modified, waived or discharged, unless such waiver, modification or discharge is agreed to in writing and signed by the Employee and the Company. No waiver by either party hereto at any time of any breach by the other party hereto, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. Nothing in this Agreement shall be construed to imply that the Employee’s employment is guaranteed for any period of time. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. Nothing in this Agreement is intended to (x) create any employment, agency, or consulting relationship between Concierge Technologies, Inc. and the Employee, and/or (y) change the at-will nature of the Employee’s employment with USCF and/or USCF Advisers.

			

 

 

	 	
			12.

				
			ENTIRE AGREEMENT. The parties agree that the terms of this Agreement are intended to be the final expression of their agreement with respect to the subject matter of this Agreement and may not be contradicted by evidence of any prior or contemporaneous Agreement.

			

 

[Signature Page Follows.]

 

 

 

 

 

IN WITNESS WHEREOF, intending to be legally bound hereby, the Company has caused this Agreement to be executed by its duly authorized executive and the Employee has executed this Agreement as of the day and year first above written.

 

 

 

	
			By Employee:

			_/s/ John Love__________________________

			John Love

			DATE: _April 18, 2022___________________

				
			For Company:

			By:

			_/s/_Nicholas Gerber__________________________________

			Representative’s Signature

			_Nicholas Gerber, Director___________________________________

			Name, Title

			 

			DATE: April 18, 2022Exhibit 10.1

 

Exhibit A

 

FORM OF VOTING AND SUPPORT AGREEMENT

 

This Voting and Support Agreement
(this “Agreement”) is made as of April 18, 2022, by and among (i) Bull Horn Holdings Corp., a British
Virgin Islands business company (together with its successors, including after giving effect to the Domestication (as defined in the Merger
Agreement (as defined below)), the “Purchaser”), (ii) Coeptis Therapeutics, Inc., a Delaware corporation
(the “Company”), and (iii) the undersigned holder (“Holder”) of capital stock and/or
securities convertible into capital stock of the Company. Any capitalized term used but not defined in this Agreement will have the meaning
ascribed to such term in the Merger Agreement.

 

WHEREAS, on or about
the date hereof, the Purchaser, the Company, and BH Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Purchaser
(“Merger Sub”), entered into that certain Agreement and Plan of Merger (as amended from time to time in accordance
with the terms thereof, the “Merger Agreement”), pursuant to which, among other matters, upon the consummation
of the transactions contemplated thereby (the ‘Closing”), Merger Sub will merge with and into the Company, with
the Company continuing as the surviving entity and a wholly-owned subsidiary of the Purchaser (the “Merger”),
and as a result of which, all of the issued and outstanding capital stock of the Company as of immediately prior to the Effective Time
shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right to receive the
merger consideration as set forth in the Merger Agreement, all upon the terms and subject to the conditions set forth in the Merger Agreement
and in accordance with the applicable provisions of the DGCL;

 

WHEREAS, it is a condition
to the consummation of the Merger that, on or prior to the Closing Date, the holders of Company Preferred Stock shall either exchange
or convert all of their issued and outstanding shares of Company Preferred Stock for shares of Company Common Stock at the applicable
conversion ratio (including any accrued or declared but unpaid dividends) in accordance with the terms of the Merger Agreement (the “Company
Preferred Stock Exchange”);

 

WHEREAS, the Board
of Directors of the Company has (a) approved and declared advisable the Merger Agreement, the Ancillary Documents, the Merger and the
other transactions contemplated by any such documents (collectively, the “Transactions”), (b) determined that
the Transactions are fair to and in the best interests of the Company and its stockholders (the “Company Stockholders”)
and (c) recommended the approval and the adoption by each of the Company Stockholders of the Merger Agreement, the Ancillary Documents,
the Merger, the Company Preferred Stock Exchange and the other Transactions; and

 

WHEREAS, as a condition
to the willingness of the Purchaser to enter into the Merger Agreement, and as an inducement and in consideration therefor, and in view
of the valuable consideration to be received by Holder thereunder, and the expenses and efforts to be undertaken by the Purchaser and
the Company to consummate the Transactions, the Purchaser, the Company and Holder desire to enter into this Agreement in order for Holder
to provide certain assurances to the Purchaser regarding the manner in which Holder is bound hereunder to vote any shares of capital stock
of the Company which Holder beneficially owns, acquires, holds or otherwise has voting power (the “Shares”)
during the period from and including the date hereof through and including the date on which this Agreement is terminated in accordance
with its terms (the “Voting Period”) with respect to the Merger Agreement, the Company Preferred Stock Exchange,
the Merger, the Ancillary Documents and the Transactions.

 

NOW, THEREFORE, in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:

 

 

 

    	 	 	 

     

    

 

1.             
Covenant to Vote in Favor of Transactions. Holder agrees, with respect to all of the Shares (and, in the case of
Section 1(b) and Section 1(f), all of the Securities (as defined below)):

 

(a)              
during the Voting Period, at each meeting of the Company Stockholders or any class or series thereof, and in each written consent
or resolutions of any of the Company Stockholders in which Holder is entitled to vote or consent, Holder hereby unconditionally and irrevocably
agrees to be present for such meeting and vote (in person or by proxy), or consent to any action by written consent or resolution with
respect to, as applicable, the Shares (i) in favor of, and adopt, the Merger, the Company Preferred Stock Exchange, the Merger Agreement,
the Ancillary Documents, any amendments to the Company’s Organizational Documents, and all of the other Transactions (and any actions
required in furtherance thereof), (ii) in favor of the other matters set forth in the Merger Agreement, and (iii) to vote the Shares in
opposition to: (A) any Acquisition Proposal and any and all other proposals (x) for the acquisition of the Company, (y) that could reasonably
be expected to delay or impair the ability of the Company to consummate the Merger, the Company Preferred Stock Exchange, the Merger Agreement
or any of the Transactions, or (z) which are in competition with or materially inconsistent with the Merger Agreement or the Ancillary
Documents; (B) other than as contemplated by the Merger Agreement, any material change in (x) the present capitalization of the Company
or any amendment of the Company’s Organizational Documents or (y) the Company’s corporate structure or business; or (C) any
other action or proposal involving any Target Company that is intended, or would reasonably be expected, to prevent, impede, interfere
with, delay, postpone or adversely affect in any material respect the Transactions or would reasonably be expected to result in any of
the conditions to the Closing under the Merger Agreement not being fulfilled;

 

(b)             
to execute and deliver all related documentation and take such other action in support of the Merger, the Company Preferred Stock
Exchange, the Merger Agreement, any Ancillary Documents and any of the Transactions, as shall reasonably be requested by the Company or
the Purchaser in order to carry out the terms and provision of this Section 1, including (i) execution and delivery to the Company
of a Letter of Transmittal and the Transmittal Documents, (ii) if applicable, delivery of Holder’s Company stock certificates, duly
endorsed for transfer, to the Company or the Exchange Agent, as applicable, and any similar or related documents and such other documents
as may be reasonably requested by the Company, the Purchaser or the Exchange Agent, as applicable, (iii) if applicable, delivery of instrument(s)
contemplating the conversion or exchange of any other Company Convertible Securities of Holder, as applicable, for shares of Company Common
Stock (or other similar documentation reasonably requested by the Purchaser, the Company or the Exchange Agent), (iv) any actions by written
consent of the Company Stockholders presented to Holder, and (v) any applicable Ancillary Documents (including, if applicable, a Lock-Up
Agreement and a Non-Competition Agreement), customary instruments of conveyance and transfer, and any consent, waiver, governmental filing,
and any similar or related documents;

 

(c)              
except for transfers expressly permitted by, and effected in accordance with, Section 3(b), not to deposit, and to cause
their Affiliates not to deposit, except as provided in this Agreement, any Shares owned by Holder or his/her/its Affiliates in a voting
trust or subject any Shares to any arrangement or agreement with respect to the voting of such Shares, unless specifically requested to
do so by the Company and the Purchaser in connection with the Merger Agreement, the Ancillary Documents and any of the Transactions;

 

(d)             
except as contemplated by the Merger Agreement or the Ancillary Documents, make, or in any manner participate in, directly or indirectly,
a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or powers of attorney
or similar rights to vote, or seek to advise or influence any Person with respect to the voting of, any shares of the Company capital
stock in connection with any vote or other action with respect to the Transactions, other than to recommend that stockholders of the Company
vote in favor of adoption of the Merger Agreement and the Transactions and any other proposal the approval of which is a condition to
the obligations of the parties under the Merger Agreement (and any actions required in furtherance thereof and otherwise as expressly
provided by Section 1 of this Agreement);

 

(e)              
to refrain from exercising any dissenters’ rights or rights of appraisal under applicable Law at any time with respect to
the Merger, the Merger Agreement, the Ancillary Documents and any of the Transactions, including pursuant to the DGCL; and

 

 

    	 	2	 

     

    

 

(f)              
without limiting Sections 1(a) and 1(b) above, to: (i) approve and consent to and with respect to any Company Preferred
Stock held by Holder, participate in the Company Preferred Stock Exchange and convert all shares of Company Preferred Stock held by Holder
for shares of Company Common Stock at the applicable conversion ratio (including any accrued or declared but unpaid dividends) as set
forth in the Company Charter in accordance with the terms of the Merger Agreement.

 

2.             
 Grant of Proxy. During the Voting Period, Holder, with respect to all of the Shares, hereby irrevocably grants to,
and appoints, the Purchaser and any designee of the Purchaser (determined in the Purchaser’s sole discretion) as Holder’s
attorney-in-fact and proxy, with full power of substitution and resubstitution, for and in Holder’s name, to vote, or cause to
be voted (including by proxy or written consent, if applicable) any Shares owned (whether beneficially or of record) by Holder, solely
on the matters and in the manner specified in Section 1 above. The proxy granted by Holder pursuant to this Section 2 is irrevocable
and is granted in consideration of the Purchaser entering into this Agreement and the Merger Agreement and incurring certain related
fees and expenses. Holder hereby affirms that such irrevocable proxy is coupled with an interest by reason of the Merger Agreement and,
except upon the termination of this Agreement in accordance with Section 5(a), is intended to be irrevocable. Holder agrees, until
this Agreement is terminated in accordance with Section 5(a), to vote its Shares in accordance with Section 1 above.

 

3.             
Other Covenants. 

 

(a)           
No Transfers. Holder agrees that during the Voting Period it shall not, and shall cause its Affiliates not to, without the
Purchaser’s prior written consent, (A) offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign
or otherwise dispose of (including by gift) (collectively, a “Transfer”), or enter into any contract, option,
derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or
consent to, a Transfer of, any or all of the Securities (as defined below); (B) grant any proxies or powers of attorney with respect to
any or all of the Securities; (C) permit to exist any lien of any nature whatsoever (other than those imposed by this Agreement, applicable
securities Laws or the Company’s Organizational Documents, as in effect on the date hereof) with respect to any or all of the Securities;
or (D) take any action that would have the effect of preventing, impeding, interfering with or adversely affecting Holder’s ability
to perform its obligations under this Agreement. The Company hereby agrees that it shall not permit any Transfer of the Securities in
violation of this Agreement. Holder agrees with, and covenants to, the Purchaser that Holder shall not request that the Company register
the Transfer (book-entry or otherwise) of any certificate or uncertificated interest representing any Security during the term of this
Agreement without the prior written consent of the Purchaser, and the Company hereby agrees that it shall not effect any such Transfer.
[Notwithstanding anything to the contrary contained in this Section 3(a), the Purchaser and the Company hereby agree that during
the Voting Period, Holder may Transfer up to an aggregate of three hundred thousand (300,000) shares of Company Common Stock in open market
transactions without the consent of the Purchaser or the Company or the requirement that any of the transferees thereof become party to
or bound by the terms of this Agreement.] 1

 

(b)           
Permitted Transfers. Section 3(a) shall not prohibit a Transfer of Shares by Holder (i) to any family member or trust
for the benefit of any family member, (ii) to any stockholder, member or partner of Holder, if an entity, (iii) to any Affiliate of Holder,
or (iv) to any person or entity if and to the extent required by any non-consensual Order, by divorce decree or by will, intestacy or
other similar applicable Law, so long as, in the case of the foregoing clauses (i), (ii), (iii) and (iv), the assignee or transferee agrees
to be bound by the terms of this Agreement and executes and delivers to the parties hereto a written consent and joinder memorializing
such agreement. During the term of this Agreement, the Company will not register or otherwise recognize the transfer (book-entry or otherwise)
of any Shares or any certificate or uncertificated interest representing any of Holder’s Shares, except as permitted by, and in
accordance with, this Section 3(b).

 

 

_________________

1
Only for Lisa Pharma LLC and Lena Pharma LLC.

 

 

    	 	3	 

     

    

 

(c)              
Changes to Securities. In the event of a stock dividend or distribution, or any change in the shares of capital stock of
the Company by reason of any stock dividend or distribution, stock split, recapitalization, combination, conversion, exchange of shares
or the like, the term “Securities” shall be deemed to refer to and include the Securities as well as all such stock dividends
and distributions and any securities into which or for which any or all of the Securities may be changed or exchanged or which are received
in such transaction. Holder agrees during the Voting Period to notify the Purchaser and the Company promptly in writing of the number
and type of any changes to Holder’s ownership of or voting control with respect to Securities, upon Holder’s acquisition or
commitment to acquire any additional Securities or upon any other changes involving Holder relating to capital stock or securities convertible
or exercisable for capital stock of the Company.

 

(d)             
Compliance with Merger Agreement. Holder agrees to not during the Voting Period take or agree or commit to take any action
that knowingly would make any representation and warranty of Holder contained in this Agreement inaccurate in any material respect. Holder
further agrees that it shall use its commercially reasonable efforts to cooperate with the Purchaser to effect the Merger, the Company
Preferred Stock Exchange, all other Transactions, the Merger Agreement, the Ancillary Documents and the provisions of this Agreement.

 

(e)              
Registration Statement. During the Voting Period, Holder agrees to provide to the Purchaser, the Company and their respective
Representatives any information regarding Holder or the Securities that is reasonably requested by the Purchaser, the Company or their
respective Representatives for inclusion in the Registration Statement.

 

(f)              
Publicity. Holder shall not issue any press release or otherwise make any public statements with respect to the Transactions
or the transactions contemplated herein without the prior written approval of the Company and the Purchaser. Holder hereby authorizes
the Company and the Purchaser to publish and disclose in any announcement or disclosure required by the SEC, Nasdaq or the Registration
Statement (including all documents and schedules filed with the SEC in connection with the foregoing), Holder’s identity and ownership
of the Securities and the nature of Holder’s commitments and agreements under this Agreement, the Merger Agreement and any other
Ancillary Documents.

 

4.             
Representations and Warranties of Holder. Holder hereby represents and warrants to the Purchaser and the Company
as follows:

 

(a)              
Binding Agreement. Holder (i) if a natural person, is of legal age to execute this Agreement and is legally competent to
do so and (ii) if not a natural person, is (A) a corporation, limited liability company, company or partnership duly organized and validly
existing under the laws of the jurisdiction of its organization and (B) has all necessary power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. If Holder is not a natural person,
the execution and delivery of this Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated
hereby by Holder has been duly authorized by all necessary corporate, limited liability or partnership action on the part of Holder, as
applicable. This Agreement, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes a legal,
valid and binding obligation of Holder, enforceable against Holder in accordance with its terms (except as such enforceability may be
limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating
to or affecting creditor’s rights, and to general equitable principles). Holder understands and acknowledges that the Purchaser
is entering into the Merger Agreement in reliance upon the execution and delivery of this Agreement by Holder.

 

 

 

    	 	4	 

     

    

 

(b)             
Ownership of Securities. As of the date hereof, Holder has beneficial ownership over the type and number of the Shares and,
to the extent applicable, the other securities issued by the Company set forth under Holder’s name on the signature page hereto
(collectively, the “Securities”), is the lawful owner of such Securities, has the sole power to vote or cause
to be voted such Securities (to the extent such Securities have associated voting rights), and has good and valid title to such Securities,
free and clear of any and all pledges, mortgages, encumbrances, charges, proxies, voting agreements, liens, adverse claims, options, security
interests and demands of any nature or kind whatsoever, other than those imposed by this Agreement, applicable securities Laws or the
Company’s Organizational Documents, as in effect on the date hereof. There are no claims for finder’s fees or brokerage commission
or other like payments in connection with this Agreement or the transactions contemplated hereby payable by Holder pursuant to arrangements
made by Holder. Except for the Shares and other securities of the Company set forth under Holder’s name on the signature page hereto,
as of the date of this Agreement, Holder is not a beneficial owner or record holder of any: (i) equity securities of the Company, (ii)
securities of the Company having the right to vote on any matters on which the holders of equity securities of the Company may vote or
which are convertible into or exchangeable for, at any time, equity securities of the Company or (iii) options, warrants or other rights
to acquire from the Company any equity securities or securities convertible into or exchangeable for equity securities of the Company.

 

(c)              
No Conflicts. No filing with, or notification to, any Governmental Authority, and no consent, approval, authorization or
permit of any other person is necessary for the execution of this Agreement by Holder, the performance of its obligations hereunder or
the consummation by it of the transactions contemplated hereby. None of the execution and delivery of this Agreement by Holder, the performance
of its obligations hereunder or the consummation by it of the transactions contemplated hereby shall (i) conflict with or result in any
breach of the certificate of incorporation, bylaws or other comparable organizational documents of Holder, if applicable, (ii) result
in, or give rise to, a violation or breach of or a default under any of the terms of any Contract or obligation to which Holder is a party
or by which Holder or any of the Securities or its other assets may be bound, or (iii) violate any applicable Law or Order, except for
any of the foregoing in clauses (i) through (iii) as would not reasonably be expected to impair Holder’s ability to perform its
obligations under this Agreement in any material respect.

 

(d)             
No Inconsistent Agreements. Holder hereby covenants and agrees that, except for this Agreement, Holder (i) has not entered
into, nor will enter into at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the
Securities inconsistent with Holder’s obligations pursuant to this Agreement, (ii) has not granted, nor will grant at any time while
this Agreement remains in effect, a proxy, a consent or power of attorney with respect to the Securities and (iii) has not entered into
any agreement or knowingly taken any action (nor will enter into any agreement or knowingly take any action) that would make any representation
or warranty of Holder contained herein untrue or incorrect in any material respect or have the effect of preventing Holder from performing
any of its material obligations under this Agreement.

 

5.             
Miscellaneous.

 

(a)              
Termination. Notwithstanding anything to the contrary contained herein, this Agreement shall automatically terminate, and
none of the Purchaser, the Company or Holder shall have any rights or obligations hereunder, upon the earliest to occur of (i) the mutual
written consent of the Purchaser, the Company and Holder, (ii) the Effective Time (following the performance of the obligations of the
parties hereunder required to be performed at or prior to the Effective Time), and (iii) the date of termination of the Merger Agreement
in accordance with its terms. The termination of this Agreement shall not prevent any party hereunder from seeking any remedies (at law
or in equity) against another party hereto or relieve such party from liability for such party’s breach of any terms of this Agreement.
Notwithstanding anything to the contrary herein, the provisions of this Section 5(a) shall survive the termination of this Agreement. 

 

(b)             
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit
of the parties hereto and their respective permitted successors and assigns. This Agreement and all obligations of Holder are personal
to Holder and may not be assigned, transferred or delegated by Holder at any time without the prior written consent of the Purchaser and
the Company, and any purported assignment, transfer or delegation without such consent shall be null and void ab initio. Each of the Company
and the Purchaser may freely assign any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether
by merger, consolidation, equity sale, asset sale or otherwise) without obtaining the consent or approval of Holder.

 

 

    	 	5	 

     

    

 

(c)              
Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection
with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person
that is not a party hereto or thereto or a successor or permitted assign of such a party.

 

(d)             
Governing Law; Jurisdiction. This Agreement and any dispute or controversy arising out of or relating to this Agreement
shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles
thereof. All Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court
located in Wilmington, Delaware (or in any appellate courts thereof) (the “Specified Courts”). Each party hereto
hereby (i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating
to this Agreement brought by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense or
otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property
is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is
improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party
agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in
any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in
any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal
delivery of copies of such process to such party at the applicable address set forth or referred to in Section 5(g). Nothing
in this Section 5(d) shall affect the right of any party to serve legal process in any other manner permitted by applicable
law.

 

(e)              
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT
IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 5(e).

 

(f)              
Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in
construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used shall include
the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and
vice versa; (ii) the term “including” (and with correlative meaning “include”) means including without limiting
the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without
limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import
shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement;
and (iv) the term “or” means “and/or”. The parties have participated jointly in the negotiation and drafting of
this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed
as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue
of the authorship of any provision of this Agreement.

 

(g)             
Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have
been duly given when delivered (i) in person, (ii) by facsimile or other electronic means (including email), with affirmative confirmation
of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three
(3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to
the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice):

 

 

 

    	 	6	 

     

    

 

	
    If to the Purchaser, to:

     

    Bull Horn Holdings Corp.

    801 S. Pointe Drive, Suite TH-1

    Miami Beach, Florida 33139

    Attn: Robert Striar, CEO

    Telephone No.: (305) 671-3341

    Email: stri@bullhornse.com

     
	
    with a copy (which will not constitute notice) to:

     

    Ellenoff Grossman & Schole LLP

    1345 Avenue of the Americas, 11th Floor

    New York, New York 10105

    Attn:  Stuart Neuhauser, Esq.;

               Matthew A. Gray, Esq.

    Facsimile No.: (212) 370-7889

    Telephone No.: (212) 370-1300

    Email:  sneuhauser@egsllp.com;

                mgray@egsllp.com

     

	
    If to the Company, to:

     

    Coeptis Therapeutics, Inc.

    105 Bradford Road, Suite 420

    Wexford, Pennsylvania 15090

    Attn: David Mehalick, CEO

    Facsimile No.: (724) 268-4118

    Telephone No.: (724) 934-6467

    Email: dave.mehalick@coeptispharma.com

     
	
    with a copy (which will not constitute notice) to:

     

    Meister Seelig & Fein LLP

    125 Park Avenue, 7th Floor

    New York, New York 10017

    Attn: Denis A. Dufresne, Esq.

    Facsimile No.: (212) 655-3535

    Telephone No.: (212) 655-3500

    Email: dad@msf-law.com

     

	If to Holder, to: the address set forth under Holder’s name on the signature page hereto, with a copy (which will not constitute notice) to, if not the party sending the notice, each of the Company and the Purchaser (and each of their copies for notices hereunder).	 
	 	 	 

(h)             
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be
waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the
Purchaser, the Company and the Holder. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof.
No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be
or construed as a further or continuing waiver of any such term, condition, or provision.

 

(i)               
Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction,
such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal
and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or
impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon
such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties will substitute for
any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and
enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

 

(j)               
Specific Performance. Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that
in the event of a breach of this Agreement by Holder, money damages will be inadequate and the Company and the Purchaser will not have
adequate remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not
performed by Holder in accordance with their specific terms or were otherwise breached. Accordingly, the Company and the Purchaser shall
be entitled to an injunction or restraining order to prevent breaches of this Agreement by Holder and to enforce specifically the terms
and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate,
this being in addition to any other right or remedy to which such party may be entitled under this Agreement, at law or in equity.

 

 

    	 	7	 

     

    

 

(k)           
Expenses. Each party shall be responsible for its own fees and expenses (including the fees and expenses of investment bankers,
accountants and counsel) in connection with the entering into of this Agreement, the performance of its obligations hereunder and the
consummation of the transactions contemplated hereby; provided, that in the event of any Action arising out of or relating to this Agreement,
the non-prevailing party in any such Action will pay its own expenses and the reasonable documented out-of-pocket expenses, including
reasonable attorneys’ fees and costs, reasonably incurred by the prevailing party.

 

(l)            
No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship among Holder, the
Company and the Purchaser, and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship
among the parties hereto or among any other Company shareholders entering into voting agreements with the Company or the Purchaser. Holder
is not affiliated with any other holder of securities of the Company entering into a voting agreement with the Company or the Purchaser
in connection with the Merger Agreement and has acted independently regarding its decision to enter into this Agreement. Nothing contained
in this Agreement shall be deemed to vest in the Company or the Purchaser any direct or indirect ownership or incidence of ownership of
or with respect to any Securities.

 

(m)            
Further Assurances. From time to time, at another party’s request and without further consideration, each party shall
execute and deliver such additional documents and take all such further action as may be reasonably necessary or desirable to consummate
the transactions contemplated by this Agreement.

 

(n)             
Entire Agreement. This Agreement (together with the Merger Agreement to the extent referred to herein) constitutes the full
and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement
relating to the subject matter hereof existing between the parties is expressly canceled; provided, that, for the avoidance
of doubt, the foregoing shall not affect the rights and obligations of the parties under the Merger Agreement or any Ancillary Document.
Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies of the Purchaser or any of the obligations
of Holder under any other agreement between Holder and the Purchaser or any certificate or instrument executed by Holder in favor of the
Purchaser, and nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of the Purchaser or
any of the obligations of Holder under this Agreement.

 

(o)             
Counterparts; Facsimile. This Agreement may be executed in multiple counterparts (including by facsimile or pdf or other
electronic document transmission), each of which shall be deemed an original, and all of which taken together shall constitute one and
the same instrument.

 

 

 

[Remainder of Page Intentionally Left Blank;
Signature Page Follows]

 

 

    	 	8	 

     

    

 

 

IN WITNESS WHEREOF,
the parties have executed this Voting and Support Agreement as of the date first written above.

 

	 	The Purchaser:	 
	 	 	 
	 	Bull Horn Holdings Corp.	 
	 	 	 	 
	 	 	 	 
	 	By:		 
	 	Name:	 	 
	 	Title:	 	 

 

 

 

	 	The Company:	 
	 	 	 
	 	Coeptis Therapeutics, Inc.	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:	 	 

 

 

 

 

 

{Signature Page to Voting Agreement}

 

 

    	 	 	 

     

    

 

 

IN WITNESS WHEREOF, the parties have executed this Voting and Support Agreement as of the date first written above.

 

Holder:

 

[________________________]      

 

	 
	By:	                                                                  
	Name:	 
	Title:	 

 

Number and Type of Securities:

 

Company Stock

 

__________ shares of Company Common Stock

 

__________ shares of Series B Convertible Preferred Stock of the Company

 

 

Other Company Securities

 

_______________________________________ number/amount and shares (including the specific type) into which securities are convertible or exercisable, as applicable.

 

Address for Notice:

 

Address:___________________________

 

Facsimile No.:_______________________

 

Telephone No.:______________________

 

Email::_____________________________  

 

 

 

{Signature Page to
Voting Agreement}

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]